XCUR Latest Press Releases

-- April 2, 2026 --

Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions Globe Newswire 4:01 PM

-- March 25, 2026 --

Exicure, Inc. Reports Full Year 2025 Financial Results Globe Newswire 4:18 PM

-- February 5, 2026 --

Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant Globe Newswire 7:00 AM

-- January 21, 2026 --

Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings Globe Newswire 7:00 AM

-- December 8, 2025 --

Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting Globe Newswire 4:30 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software